Stay updated on Ivermectin in Severe COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Ivermectin in Severe COVID-19 Clinical Trial page.

Latest updates to the Ivermectin in Severe COVID-19 Clinical Trial page
- CheckyesterdayChange DetectedPage revision updated from v3.2.0 to v3.3.1.SummaryDifference0.0%

- Check9 days agoChange Detected- Added comprehensive results data to the Study Results page, including Overall Number of Participants Analyzed, baseline characteristics, and multiple clinical/laboratory outcome measures and adverse events. - Also included mutation screening results and notes on exclusions due to detected mutations.SummaryDifference3%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedNo significant changes detected in the data, outcomes, or participant characteristics; the content appears unchanged between screenshots and any differences are purely cosmetic. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check51 days agoChange Detected- Added a government funding notice and operating-status details; updated operating info link references. - Version updated from v3.0.2 to v3.2.0.SummaryDifference0.8%

- Check53 days agoChange DetectedUpgrade of the page version from v3.0.2 to v3.1.0; a metadata/versioning change with no impact on core content or user-facing data.SummaryDifference0.0%

- Check67 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the Back to Top navigation item was removed. No other significant content changes.SummaryDifference0.0%

Stay in the know with updates to Ivermectin in Severe COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ivermectin in Severe COVID-19 Clinical Trial page.